Altre lingue MaxCyte, Inc.

Azioni

MXCT

US57777K1060

Tempo differito London S.E. Altri mercati azionari 09:00:22 11/06/2024			Variaz. 5gg	Var. 1 gen.
388,5 ^GBX	+3,60%		+12,61%	+10,21%

00:02	L'insider di Maxcyte ha acquistato azioni per un valore di 489.066 dollari, secondo un recente deposito SEC	MT
22/05	MaxCyte stringe un accordo con Legend Biotech per la fornitura di tecnologia	AN

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Maxcyte Insider Bought Shares Worth $489,066, According to a Recent SEC Filing	00:02
MaxCyte : Participation in Upcoming Investor Conference	29/05
MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference	29/05
MaxCyte inks deal with Legend Biotech for tech supply	22/05
MaxCyte Signs License Deal With Legend Biotech for Cell Therapy Program	22/05
MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development	22/05
MaxCyte, Inc. Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development	22/05
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance	09/05
MaxCyte announces filing of Form 10-Q for the quarterly period ended March 31, 2024	09/05
MaxCyte Shares Rise Sharply After Q1 Results Beat	08/05
MaxCyte shares rise amid double-digit revenue increase	08/05
Earnings Flash (MXCT.L) MAXCYTE Posts Q1 Revenue $11.3M	08/05
Earnings Flash (MXCT.L) MAXCYTE Reports Q1 Loss $-0.09	08/05
MaxCyte, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Earnings Flash (MXCT) MAXCYTE Reports Q1 Revenue $11.3M, vs. Street Est of $7.5M	07/05
MaxCyte Reports First Quarter 2024 Financial Results and Updates 2024 Guidance	07/05
Maxcyte, Inc. Affirms Revenue Guidance for the Full Year 2024	07/05
MaxCyte, Inc. - Notice of AGM	06/05
Jefferies cuts AJ Bell; Deutsche likes ConvaTec	03/05
MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024	10/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue MaxCyte, Inc.

Azioni

MXCT

US57777K1060

Altre lingue

Filtri